Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
DexCom Inc (DXCM)  
$115.95 2.14 (1.88%) as of 4:30 Fri 6/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 389,580,000
Market Cap: 45.17(B)
Last Volume: 1,813,692 Avg Vol: 1,929,144
52 Week Range: $75.49 - $140.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  487
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 64,005 267,979 302,595 574,627
Total Sell Value $8,769,441 $35,482,928 $39,449,301 $69,910,840
Total People Sold 6 8 13 15
Total Sell Transactions 10 24 47 82
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 2306
  Page 29 of 93  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-11-12 4 AS $142.25 $1,634,284 D/D (11,161) 320,837     -
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-11-12 4 OE $4.58 $51,117 D/D 11,161 331,998     -
   Ace Heather S SVP Human Resources   •       –      –    2018-11-09 4 AS $145.91 $627,294 D/D (4,258) 65,081     -
   Abbey Donald EVP, Quality & Regulatory Afrs   •       –      –    2018-11-09 4 AS $147.62 $1,575,159 D/D (10,550) 88,089     -
   Murphy Patrick Michael SVP, GC & Chief Compliance Off   •       –      –    2018-11-09 4 AS $148.11 $59,244 D/D (400) 30,508     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2018-10-23 4 AS $128.66 $223,466 I/I (1,736) 17,358     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2018-10-23 4 AS $128.61 $401,253 D/D (3,114) 110,746     -
   Balo Andrew K EVP, Reg. Strategy, Clinical   •       –      –    2018-10-12 4 AS $124.49 $623,934 D/D (5,000) 83,105     -
   Murphy Patrick Michael SVP, GC & Chief Compliance Off   •       –      –    2018-10-10 4 AS $122.20 $48,880 D/D (400) 30,908     -
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-10-08 4 AS $124.32 $1,392,433 D/D (11,161) 320,837     -
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-10-08 4 OE $4.58 $51,117 D/D 11,161 331,998     -
   Altman Steven R Director   –       •      –    2018-10-01 4 AS $132.68 $339,134 I/I (2,500) 55,355     -
   Leach Jacob Steven Chief Technology Officer   •       –      –    2018-09-28 4 AS $142.96 $6,852,139 I/I (47,600) 0     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2018-09-24 4 AS $138.69 $439,841 D/D (3,114) 113,860     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2018-09-24 4 AS $138.25 $245,129 I/I (1,736) 19,094     -
   Balo Andrew K EVP, Reg. Strategy, Clinical   •       –      –    2018-09-14 4 AS $144.46 $725,851 D/D (5,000) 88,105     -
   Leach Jacob Steven SVP, Research & Development   •       –      –    2018-09-12 4 OE $5.92 $88,800 D/D 15,000 109,284     -
   Blackford Quentin S. EVP, CFO, PFO & PAO   •       –      –    2018-09-11 4 AS $145.23 $1,241,028 D/D (8,440) 87,131     -
   Leach Jacob Steven SVP, Research & Development   •       –      –    2018-09-10 4 S $143.76 $663,286 D/D (4,614) 94,284     -
   Ace Heather S SVP Human Resources   •       –      –    2018-09-10 4 S $143.76 $263,360 D/D (1,832) 69,339     -
   Moy Jeffrey SVP, Operations   •       –      –    2018-09-10 4 AS $143.35 $822,256 I/I (5,736) 16,711     -
   Moy Jeffrey SVP, Operations   •       –      –    2018-09-10 4 A $0.00 $0 I/I 17,386 22,447     -
   Moy Jeffrey SVP, Operations   •       –      –    2018-09-10 4 AS $0.00 $0 D/D (17,386) 46,534     -
   Moy Jeffrey SVP, Operations   •       –      –    2018-09-10 4 AS $143.76 $660,411 D/D (4,594) 63,920     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2018-09-10 4 S $143.76 $788,210 D/D (5,483) 116,974     -

  2306 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 29 of 93
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed